Loading briefing details...
News Abstract
By: PointLine Media Research & Editorial Team
Topic:Business,Health,Industry,Lifestyle
August 18, 2026
Freyja Healthcare has secured FDA 510(k) clearance for its VereSee device, a 2mm mini laparoscope equipped with the VisualEntry system. The device is designed to provide surgeons with direct visualization during the initial stages of abdominal access in minimally invasive procedures.
By integrating imaging into the entry process, the system aims to replace traditional blind access techniques. This allows surgeons to monitor anatomical structures from the moment the procedure begins, rather than waiting until access is fully established.
The platform combines single-use components for entry with reusable imaging technology. This modular design is intended to integrate into existing surgical workflows while managing costs for medical facilities.
The medical device industry is increasingly focused on miniaturizing surgical tools to reduce patient trauma and improve procedural efficiency. By shifting visualization to the very first step of laparoscopic surgery, companies are attempting to mitigate the risks associated with traditional, non-visualized abdominal entry.
This trend reflects a broader push toward enhancing safety during routine surgeries through better imaging. As hospitals look for ways to streamline operations, technologies that combine multiple surgical functions into a single, compact device are gaining traction in both hospital and ambulatory settings.